Background. Propofol is a popular intravenous anesthetic and varieties of formulations were produced from different laboratories. The present study compared efficacy of propofol of different laboratories and different concentrations (1 and 2%) during induction of anesthesia. Methods. Seventy-five scheduled surgical patients were randomly allocated into three groups. The patients of group D1 received AstraZeneca Diprivan 1% (Osaka, Japan) at a rate of 40 mg kg(-1) h(-1). Group M1 was given 1% Maruishi (Maruishi Pharmaceutical, Osaka, Japan) and group M2 was given 2% formulation at the same rate of propofol. Achieving hypnosis was defined as failure to open their eyes in response to a verbal command and the venous blood sample was withdrawn. Results. The hypnotic doses of M2 were significantly larger (D1: 91.4 ± 30.9, M1: 90.7 ± 26.7, and M2: 118.4 ± 40.2 mg, resp. (mean ± SD). p < 0.005). Age and gender were selected as statistically significant covariates using general linear model-ANOVA. The blood concentration showed no significant difference among the groups (3.73 ± 2.34, 4.10 ± 3.04, and 4.70 ± 2.12 μg mL(-1), resp.). Conclusion. The required dose of propofol was different among the formulations; however, the serum concentration showed no significant difference. This trial is registered with UMIN Clinical Trial Registry: UMIN000019925.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745982PMC
http://dx.doi.org/10.1155/2016/9178523DOI Listing

Publication Analysis

Top Keywords

efficacy propofol
8
induction anesthesia
8
osaka japan
8
concentration difference
8
propofol
5
influence differences
4
differences solvents
4
solvents concentration
4
concentration efficacy
4
propofol induction
4

Similar Publications

Online monitoring of propofol concentrations in exhaled breath.

Heliyon

December 2024

Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Propofol, a widely used intravenous anesthetic agent, requires accurate monitoring to ensure therapeutic efficacy and prevent oversedation. Recent developments in modern analytical instrumentation have led to significant breakthroughs in on-line analysis of exhaled breath. This review discusses several sophisticated analytical methods that have been explored for noninvasive, real-time monitoring of propofol concentrations, including proton transfer reaction mass spectrometry, selected ion flow tube mass spectrometry, ion mobility spectrometry, and gas chromatography coupled to surface acoustic wave sensors.

View Article and Find Full Text PDF
Article Synopsis
  • The study focused on the effectiveness of propofol versus dexmedetomidine in reducing emergence delirium (ED) in pediatric patients after anesthesia, finding a wide incidence range (2% to 80%).
  • Eighty children aged 2-6 undergoing short surgeries were treated with either propofol or dexmedetomidine before surgery, with ED assessed using specific scales afterward.
  • Results showed a significantly lower ED rate in the dexmedetomidine group (2.5% vs. 70%), along with reduced postoperative pain, indicating that dexmedetomidine is more effective than propofol for these patients.
View Article and Find Full Text PDF

Background: The combination of esketamine and propofol has become a common choice for total intravenous anesthesia in hysteroscopic procedures. However, the optimal effective dose has not yet been determined. The aim of this study was to determine the median effective dose (ED) and 95% effective dose (ED) of esketamine compounded with propofol for painless hysteroscopy.

View Article and Find Full Text PDF

Dexmedetomidine in colon cancer surgery: Evaluating its impact and efficacy.

World J Gastrointest Surg

December 2024

Department of Anaesthesiology, All India Institute of Medical Sciences, Bathinda 151001, India.

We present an editorial on an article that highlights the benefits of dexmedetomidine (Dex) in colon cancer surgeries, which have been thoroughly investigated in the referenced publication involving 117 subjects. Of these patients, 59 (group A) received Dex before anesthesia induction, while 58 (group B) received normal saline. Group A patients demonstrated several advantages over Group B, including lower propofol and remifentanil requirements, improved cerebral oxygenation as measured by regional cerebral oxygen saturation, better hemodynamic stability, and reduced incidence of postoperative cognitive dysfunction.

View Article and Find Full Text PDF

We presented a 7-year-old boy with refractory Epileptic Encephalopathy with Spike-and-Wave Activation in Sleep (EE-SWAS) successfully managed with a combination of propofol and midazolam. His seizures began at age 2, initially controlled by multiple antiseizure medications (ASMs) for almost three years. At age 5, seizures recurred with electroencephalography (EEG) showing electrical status epilepticus in sleep (ESES) and a spike-wave index (SWI) of 85 %.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!